Literature DB >> 24279891

Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.

Haiping He1, Tokiko Nagamura-Inoue, Hajime Tsunoda, Miki Yuzawa, Yuki Yamamoto, Pariko Yorozu, Hideki Agata, Arinobu Tojo.   

Abstract

BACKGROUND: Umbilical cord Wharton's jelly (WJ) is a rich source of mesenchymal stem cells (MSCs) similar to bone marrow (BM) and adipose tissues. Stage-specific embryonic antigen (SSEA)4 has been reported as a stem cell marker in BM-derived MSCs, but whether SSEA4(+) cells have growth and differentiation advantages over SSEA4(-) cells remains controversial. To gain insight into the role of SSEA4, we studied SSEA4(+) cells in WJ-derived MSCs (WJ-MSCs).
METHODS: WJ-MSCs were collected by the explant (WJe-MSCs) or collagenase methods (WJc-MSCs) and analyzed by flow cytometry and reverse-transcription polymerase chain reaction (RT-PCR). To evaluate whether culture conditions influenced the SSEA4 expression, WJe-MSCs were cultured in the medium supplemented with different fetal bovine serum (FBS) concentrations.
RESULTS: SSEA4 was expressed for a long-term culture. In contrast, SSEA3(+) disappeared rapidly in early passages of the culture. The incidence of SSEA4(+) and SSEA3(+) cells was similar between WJe-MSCs and WJc-MSCs at passages P0-P9, except for transient depletion of SSEA4 expression in early passages of WJe-MSCs. These were CD73(+)CD105(+) cells that express embryonic stem cell markers detected by RT-PCR. No differences in growth and differentiation ability of osteocytes and adipocytes were observed between the sorted SSEA4(+) cells and SSEA4(-) cells. Further, SSEA4 expression in WJe-MSCs was significantly correlated with FBS concentration in the culture medium. DISCUSSION: SSEA4, which may display altered expression profiles in response to culture conditions, may not be an essential marker of WJ-MSC multipotency.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24279891     DOI: 10.1089/ten.TEA.2013.0333

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  12 in total

1.  Liver Kinase B1 Fine-Tunes Lineage Commitment of Human Fetal Synovium-Derived Stem Cells.

Authors:  Sheng Zhou; Yawen Fu; Xiao-Bing Zhang; Ming Pei
Journal:  J Orthop Res       Date:  2019-08-30       Impact factor: 3.494

Review 2.  Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.

Authors:  Tokiko Nagamura-Inoue; Haiping He
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

3.  Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.

Authors:  Haiping He; Tokiko Nagamura-Inoue; Atsuko Takahashi; Yuka Mori; Yuki Yamamoto; Takahisa Shimazu; Hajime Tsunoda; Arinobu Tojo
Journal:  Int J Hematol       Date:  2015-07-31       Impact factor: 2.490

4.  In Vitro Characterization of Human Mesenchymal Stem Cells Isolated from Different Tissues with a Potential to Promote Complex Bone Regeneration.

Authors:  Áron Szepesi; Zsolt Matula; Anna Szigeti; György Várady; József Szalma; Gyula Szabó; Ferenc Uher; Balázs Sarkadi; Katalin Német
Journal:  Stem Cells Int       Date:  2016-11-24       Impact factor: 5.443

5.  Mesenchymal stroma cells in peritoneal dialysis effluents from patients.

Authors:  Bin Liu; Qiunong Guan; Jing Li; Gerald da Roza; Hao Wang; Caigan Du
Journal:  Hum Cell       Date:  2017-01-05       Impact factor: 4.174

Review 6.  Mesenchymal stromal cells as a potential therapeutic for neurological disorders.

Authors:  Takeo Mukai; Arinobu Tojo; Tokiko Nagamura-Inoue
Journal:  Regen Ther       Date:  2018-08-24       Impact factor: 3.419

7.  Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting.

Authors:  Zikuan Leng; Dongming Sun; Zihao Huang; Iman Tadmori; Ning Chiang; Nikhit Kethidi; Ahmed Sabra; Yoshihiro Kushida; Yu-Show Fu; Mari Dezawa; Xijing He; Wise Young
Journal:  Cell Transplant       Date:  2019-04-18       Impact factor: 4.064

Review 8.  Umbilical Cord Tissue-Derived Cells as Therapeutic Agents.

Authors:  Olga Maslova; Miroslav Novak; Peter Kruzliak
Journal:  Stem Cells Int       Date:  2015-07-12       Impact factor: 5.443

9.  Is There a Noninvasive Source of MSCs Isolated with GMP Methods with Better Osteogenic Potential?

Authors:  Carla C G Pinheiro; Alessander Leyendecker Junior; Daniela Y S Tanikawa; José Ricardo Muniz Ferreira; Reza Jarrahy; Daniela F Bueno
Journal:  Stem Cells Int       Date:  2019-11-06       Impact factor: 5.443

10.  Effect of Long-Term 3D Spheroid Culture on WJ-MSC.

Authors:  Agnieszka Kaminska; Aleksandra Wedzinska; Marta Kot; Anna Sarnowska
Journal:  Cells       Date:  2021-03-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.